Medicine development startup Brii Biosciences has launched with funding from investors including the WuXi AppTec-backed 6 Dimensions Capital.
China-based medicine provider Brii Biosciences officially launched yesterday with $260m of funding from investors including 6 Dimensions Capital, the investment firm co-founded by pharmaceutical firm WuXi AppTec.
6 Dimensions, formed by WuXi AppTec and venture capital firm Frontline BioVentures, was joined by VC firms Arch Venture Partners and Sequoia Capital, private equity firms Boyu Capital and Yunfeng Capital, and asset management firm Blue Pool Capital.
Brii Bio intends to combine strategic partnerships, data analysis and research and development to…
